Fundz

Aurobindo Pharma's Apitoria buys 80% of A1 Biochem

PRIVATEJul 23, 2026

Acquiring Company

Aurobindo Pharma Limited

Acquired Company

A1 Biochem Group

United StatesHyderabadManufacturingBiotechnologyPharmaceuticalBiotechnologyPharmaceutical

Description

Aurobindo Pharma Limited's subsidiary, Apitoria Pharma, has acquired an 80% stake in A1 Biochem Group's CRO business for USD 17 million. This acquisition will enable Aurobindo to enhance its research and development capabilities while expanding its presence in the Active Pharmaceutical Ingredients market. The deal is expected to close within 90 to 120 days, pending regulatory approvals.

Quick answer

Aurobindo Pharma Limited is acquiring A1 Biochem Group, announced July 23, 2026. Aurobindo Pharma Limited is based in United States.

How much did Aurobindo Pharma Limited pay for A1 Biochem Group?
The deal value was not disclosed.
What does Aurobindo Pharma Limited do?
Aurobindo Pharma Limited is a Midcap Pharma stock engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services.
Where are Aurobindo Pharma Limited and A1 Biochem Group based?
Aurobindo Pharma Limited is based in United States. A1 Biochem Group is based in Hyderabad, Telangana, India.
Who are the decision-makers at Aurobindo Pharma Limited?
Fundz holds 1 contact at Aurobindo Pharma Limited. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Pharmaceutical and Pharmaceutical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Aurobindo Pharma Limited, and when

When Aurobindo Pharma Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Aurobindo Pharma Limited raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aurobindo Pharma Limited, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aurobindo Pharma Limited. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aurobindo Pharma Limited

Location

United States

About

Aurobindo Pharma Limited is a Midcap Pharma stock engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aurobindo Pharma Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Suresh
Senior decision-maker at this company
••••••••@••••••••

See Suresh's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aurobindo Pharma Limited's next move

Learn about Strategic plan

Frequently asked

Who acquired A1 Biochem Group?

A1 Biochem Group was acquired by Aurobindo Pharma Limited, based in United States. The deal was reported on July 23, 2026. Aurobindo Pharma Limited is a Midcap Pharma stock engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services. Aurobindo Pharma Limited is privately held and operates in Manufacturing.

When did Aurobindo Pharma Limited acquire A1 Biochem Group?

Aurobindo Pharma Limited's acquisition of A1 Biochem Group was reported on July 23, 2026. Aurobindo Pharma Limited's subsidiary, Apitoria Pharma, has acquired an 80% stake in A1 Biochem Group's CRO business for USD 17 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does A1 Biochem Group do?

A1 Biochem Group is a Contract Research Organization (CRO) that offers comprehensive chemistry services to pharmaceutical companies and academic institutions. It is privately held, operating in Biotechnology, and is based in Hyderabad.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.